Literature DB >> 33199914

Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes.

James Schiemer1, Reto Horst1, Yilin Meng1, Justin I Montgomery1, Yingrong Xu1, Xidong Feng1, Kris Borzilleri1, Daniel P Uccello1, Carolyn Leverett1, Stephen Brown1, Ye Che1, Matthew F Brown1, Matthew M Hayward1, Adam M Gilbert1, Mark C Noe1, Matthew F Calabrese2.   

Abstract

Heterobifunctional chimeric degraders are a class of ligands that recruit target proteins to E3 ubiquitin ligases to drive compound-dependent protein degradation. Advancing from initial chemical tools, protein degraders represent a mechanism of growing interest in drug discovery. Critical to the mechanism of action is the formation of a ternary complex between the target, degrader and E3 ligase to promote ubiquitination and subsequent degradation. However, limited insights into ternary complex structures exist, including a near absence of studies on one of the most widely co-opted E3s, cellular inhibitor of apoptosis 1 (cIAP1). In this work, we use a combination of biochemical, biophysical and structural studies to characterize degrader-mediated ternary complexes of Bruton's tyrosine kinase and cIAP1. Our results reveal new insights from unique ternary complex structures and show that increased ternary complex stability or rigidity need not always correlate with increased degradation efficiency.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33199914     DOI: 10.1038/s41589-020-00686-2

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  50 in total

1.  Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Authors:  K M Sakamoto; K B Kim; A Kumagai; F Mercurio; C M Crews; R J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).

Authors:  Nobumichi Ohoka; Keiichiro Okuhira; Masahiro Ito; Katsunori Nagai; Norihito Shibata; Takayuki Hattori; Osamu Ujikawa; Kenichiro Shimokawa; Osamu Sano; Ryokichi Koyama; Hisashi Fujita; Mika Teratani; Hirokazu Matsumoto; Yasuhiro Imaeda; Hiroshi Nara; Nobuo Cho; Mikihiko Naito
Journal:  J Biol Chem       Date:  2017-02-02       Impact factor: 5.157

3.  Targeted protein degradation: expanding the toolbox.

Authors:  Matthieu Schapira; Matthew F Calabrese; Alex N Bullock; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2019-10-30       Impact factor: 84.694

4.  Catalytic in vivo protein knockdown by small-molecule PROTACs.

Authors:  Daniel P Bondeson; Alina Mares; Ian E D Smith; Eunhwa Ko; Sebastien Campos; Afjal H Miah; Katie E Mulholland; Natasha Routly; Dennis L Buckley; Jeffrey L Gustafson; Nico Zinn; Paola Grandi; Satoko Shimamura; Giovanna Bergamini; Maria Faelth-Savitski; Marcus Bantscheff; Carly Cox; Deborah A Gordon; Ryan R Willard; John J Flanagan; Linda N Casillas; Bartholomew J Votta; Willem den Besten; Kristoffer Famm; Laurens Kruidenier; Paul S Carter; John D Harling; Ian Churcher; Craig M Crews
Journal:  Nat Chem Biol       Date:  2015-06-10       Impact factor: 15.040

5.  Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.

Authors:  Jing Lu; Yimin Qian; Martha Altieri; Hanqing Dong; Jing Wang; Kanak Raina; John Hines; James D Winkler; Andrew P Crew; Kevin Coleman; Craig M Crews
Journal:  Chem Biol       Date:  2015-06-04

6.  Delineating the role of cooperativity in the design of potent PROTACs for BTK.

Authors:  Adelajda Zorba; Chuong Nguyen; Yingrong Xu; Jeremy Starr; Kris Borzilleri; James Smith; Hongyao Zhu; Kathleen A Farley; WeiDong Ding; James Schiemer; Xidong Feng; Jeanne S Chang; Daniel P Uccello; Jennifer A Young; Carmen N Garcia-Irrizary; Lara Czabaniuk; Brandon Schuff; Robert Oliver; Justin Montgomery; Matthew M Hayward; Jotham Coe; Jinshan Chen; Mark Niosi; Suman Luthra; Jaymin C Shah; Ayman El-Kattan; Xiayang Qiu; Graham M West; Mark C Noe; Veerabahu Shanmugasundaram; Adam M Gilbert; Matthew F Brown; Matthew F Calabrese
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

7.  Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics.

Authors:  Ashley R Schneekloth; Mathieu Pucheault; Hyun Seop Tae; Craig M Crews
Journal:  Bioorg Med Chem Lett       Date:  2008-07-31       Impact factor: 2.823

8.  A chemical approach for global protein knockdown from mice to non-human primates.

Authors:  Xiuyun Sun; Jun Wang; Xia Yao; Wen Zheng; Yang Mao; Tianlong Lan; Liguo Wang; Yonghui Sun; Xinyi Zhang; Qiuye Zhao; Jianguo Zhao; Rui-Ping Xiao; Xiuqin Zhang; Guangju Ji; Yu Rao
Journal:  Cell Discov       Date:  2019-02-05       Impact factor: 10.849

9.  BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

Authors:  William Farnaby; Manfred Koegl; Michael J Roy; Claire Whitworth; Emelyne Diers; Nicole Trainor; David Zollman; Steffen Steurer; Jale Karolyi-Oezguer; Carina Riedmueller; Teresa Gmaschitz; Johannes Wachter; Christian Dank; Michael Galant; Bernadette Sharps; Klaus Rumpel; Elisabeth Traxler; Thomas Gerstberger; Renate Schnitzer; Oliver Petermann; Peter Greb; Harald Weinstabl; Gerd Bader; Andreas Zoephel; Alexander Weiss-Puxbaum; Katharina Ehrenhöfer-Wölfer; Simon Wöhrle; Guido Boehmelt; Joerg Rinnenthal; Heribert Arnhof; Nicola Wiechens; Meng-Ying Wu; Tom Owen-Hughes; Peter Ettmayer; Mark Pearson; Darryl B McConnell; Alessio Ciulli
Journal:  Nat Chem Biol       Date:  2019-06-10       Impact factor: 15.040

10.  Plasticity in binding confers selectivity in ligand-induced protein degradation.

Authors:  Radosław P Nowak; Stephen L DeAngelo; Dennis Buckley; Zhixiang He; Katherine A Donovan; Jian An; Nozhat Safaee; Mark P Jedrychowski; Charles M Ponthier; Mette Ishoey; Tinghu Zhang; Joseph D Mancias; Nathanael S Gray; James E Bradner; Eric S Fischer
Journal:  Nat Chem Biol       Date:  2018-06-11       Impact factor: 15.040

View more
  12 in total

Review 1.  PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).

Authors:  Ming He; Chaoguo Cao; Zhihao Ni; Yongbo Liu; Peilu Song; Shuang Hao; Yuna He; Xiuyun Sun; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

Review 2.  Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges.

Authors:  Chao Wang; Yujing Zhang; Tingting Zhang; Lingyu Shi; Zhongmin Geng; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 3.  Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents.

Authors:  Chao Wang; Yujing Zhang; Lingyu Shi; Shanbo Yang; Jing Chang; Yingjie Zhong; Qian Li; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation.

Authors:  Charles E Hendrick; Jeff R Jorgensen; Charu Chaudhry; Iulia I Strambeanu; Jean-Francois Brazeau; Jamie Schiffer; Zhicai Shi; Jennifer D Venable; Scott E Wolkenberg
Journal:  ACS Med Chem Lett       Date:  2022-06-20       Impact factor: 4.632

5.  Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.

Authors:  Nan Bai; Sven A Miller; Grigorii V Andrianov; Max Yates; Palani Kirubakaran; John Karanicolas
Journal:  J Chem Inf Model       Date:  2021-02-24       Impact factor: 4.956

Review 6.  Proteolysis-targeting chimeras (PROTACs) in cancer therapy.

Authors:  Xinyi Li; Wenchen Pu; Qingquan Zheng; Min Ai; Song Chen; Yong Peng
Journal:  Mol Cancer       Date:  2022-04-11       Impact factor: 27.401

Review 7.  Advancing targeted protein degradation for cancer therapy.

Authors:  Brandon Dale; Meng Cheng; Kwang-Su Park; H Ümit Kaniskan; Yue Xiong; Jian Jin
Journal:  Nat Rev Cancer       Date:  2021-06-15       Impact factor: 60.716

Review 8.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288

Review 9.  Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms.

Authors:  Frances P Rodriguez-Rivera; Samuel M Levi
Journal:  ACS Cent Sci       Date:  2021-06-16       Impact factor: 14.553

10.  A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models.

Authors:  Xufen Yu; Dongxu Li; Jithesh Kottur; Yudao Shen; Huen Suk Kim; Kwang-Su Park; Yi-Hsuan Tsai; Weida Gong; Jun Wang; Kyogo Suzuki; Joel Parker; Laura Herring; H Ümit Kaniskan; Ling Cai; Rinku Jain; Jing Liu; Aneel K Aggarwal; Gang Greg Wang; Jian Jin
Journal:  Sci Transl Med       Date:  2021-09-29       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.